All > Massachusetts Investigators

Karen K Miller, MD

Massachusetts General Hospital

Boston, Massachusetts - 02114

CLINICAL TRIALS 2
CONDITIONS6
INTERVENTIONS2
SINCE2005

Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents

May 2005 - June 2007

The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa

September 2008 - August 2010

Obesity

Anorexia

Anorexia Nervosa

Overweight

Osteoporosis

Osteoporosis, Postmenopausal

Placebo

Teriparatide

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Karen K Miller, MD

Massachusetts General Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP